Hi, friends, being AI enthusiast, I'm an MBA, CEO and CPO who loves building products. I share my insights here.) Hi, friends, being AI enthusiast, I'm an MBA, CEO and CPO who loves building products.
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...
The ability to write parts of SQL queries in natural language will help developers speed up their work, analysts say. Google is previewing a new AI-driven feature in its BigQuery data warehouse that ...
According to God of Prompt on Twitter, MIT researchers have introduced a new prompt engineering technique called 'Recursive Meta-Cognition' that enables ChatGPT to reason like a team of experts rather ...
Abstract: SQL:1999 recursive queries are almost a quarter century old. In this standard the recursive queries have the form of recursive common table expressions. In recent years vendors of almost all ...
On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...
RXRX has upcoming data in H2'25 from the TUPELO trial of REC-4881 in familial adenomatous polyposis. The company will also report data from the ELUCIDATE trial of REC-617 in H2'25. A previous update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results